IDXX vs PACB · P/E 40, rev $2.36B vs rev $76.2M
IDEXX Laboratories Inc (IDXX) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. PACB currently screens at market cap $387.1M.
Not investment advice. Open the IDXX and PACB stock pages for the full models.
Not investment advice.